By pinki / May 14, 2022 ← Go back Biosimilars Implementation in the United States: Where Opportunities RemainJorge J. Garcia, PharmD, MS, MHA, MBA, FACHE← Go back Biosimilars Implementation in the United States: Where Opportunities RemainJorge J. Garcia, PharmD, MS, MHA, MBA, FACHE